Luis M Montuenga (Luis Montuenga)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Chronic Obstructive Pulmonary Disease

Squamous Cell Carcinoma

Ejection Fraction

Top Venues

Antioxidants (Basel, Switzerland)

Cancer immunology, immunotherapy : CII

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

A Elizabeth Córdoba-Lanús, Luis M Montuenga, Angélica Domínguez de-Barros, Alexis Oliva, Delia Mayato, Ana Remírez-Sanz, Francisca Gonzalvo, Bartolomé Celli, Javier J Zulueta, Ciro Casanova
Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers. Antioxidants (Basel, Switzerland) 13 (2) (2024)
A Elizabeth Córdoba-Lanús, Luis M Montuenga, Angélica Domínguez de-Barros, Alexis Oliva, Delia Mayato, Ana Remírez-Sanz, Francisca Gonzalvo, Bartolomé Celli, Javier J Zulueta, Ciro Casanova
Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers. Antioxidants (Basel, Switzerland) 13 (2) (2024)
Francisco Expósito, Miriam Redrado, Maeva Houry, Katherine Hastings, Magdalena Molero, Teresa Lozano, José Luis Solórzano, Julián Sanz, Vera Adradas, Ramon Amat, Esther Redin, Sergio Leon, Naroa Legarra, Javier Garcia, Angel Rodriguez, Karmele Valencia, Camila Robles-Oteíza, Giorgia Foggetti, Nerea Otegui, Enriqueta Felip Font, Juan Jose Lasarte, Luis G Paz-Ares, Jon Zugazagoitia, Katerina Politi, Luis M Montuenga, Alfonso Calvo
PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer research (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Estrogen receptor and immune checkpoint inhibitors: new partners in lung cancer? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karmele Valencia, Mirari Echepare, Andrea Pasquier, Cristina Bértolo, Cristina Sainz, Ibon Tamayo-Uria, Beñat Picabea, Graziella Bosco, Roman K Thomas, Jackeline Agorreta, José María López-Picazo, Joan Frigola, Ramon Amat, Alfonso Calvo, Enriqueta Felip Font, Ignacio Melero Bermejo, Luis M Montuenga
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity. The Journal of experimental medicine 219 (12) (2022)
Ana Belén Herrera-Campos, Esteban Zamudio-Martinez, Daniel Delgado-Bellido, Mónica Fernández-Cortés, Luis M Montuenga, Francisco Javier Oliver, Angel Garcia-Diaz
Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System. Cancers 14 (11) (2022)
Irati Garmendia, Esther Redin, Luis M Montuenga, Alfonso Calvo
YES1: A Novel Therapeutic Target and Biomarker in Cancer. Molecular cancer therapeutics 21 (9) (2022)
Mario Sánchez-Canteli, Luis Juesas, Irati Garmendia, María Otero-Rosales, Alfonso Calvo, Monica Alvarez-Fernández, Aurora Astudillo, Luis M Montuenga, Juana María García-Pedrero, Juan Pablo Rodrigo
Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas. International journal of molecular sciences 23 (19) (2022)
Karmele Valencia, Cristina Sainz, Cristina Bértolo, Gabriel de Biurrun, Jackeline Agorreta, Arantza Azpilikueta, Marta J Larrayoz, Graziella Bosco, Carolina Zandueta, Miriam Redrado, Esther Redín, Francisco Expósito, Diego Serrano, Mirari Echepare, Daniel Ajona, Ignacio Melero, Ruben Pio, Roman Thomas, Alfonso Calvo, Luis M Montuenga
Two alternative cell line models for the study of multiorganic metastasis and immunotherapy in Lung Squamous Cell Carcinoma. Disease models & mechanisms (2021)
Karmele Valencia, Luis M Montuenga
Exosomes in Liquid Biopsy: The Nanometric World in the Pursuit of Precision Oncology. Cancers 13 (9) (2021)
Cora Palanca-Ballester, Aitor Rodriguez-Casanova, Susana Torres, Silvia Calabuig-Fariñas, Francisco Expósito, Angel Rodriguez, Esther Redin, Karmele Valencia, Eloísa Jantus-Lewintre, Angel Diaz-Lagares, Luis M Montuenga, Juan Sandoval, Alfonso Calvo
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers 13 (12) (2021)
Mario Sánchez-Canteli, Luis Juesas, Esther Redin, Alfonso Calvo, Fernando López, Aurora Astudillo, Luis M Montuenga, Juana María García-Pedrero, Juan Pablo Rodrigo
Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas. Cancers 13 (9) (2021)
Denis Horgan, Gennaro Ciliberto, PierFranco Conte, Giuseppe Curigliano, Luis Seijo, Luis M Montuenga, Marina Garassino, Frederique Penault-Llorca, Fabrizia Galli, Isabelle L Ray-Coquard, Denis Querleu, Peter Riegman, Keith Kerr, Hein Van Poppel, Anders Bjartell, Giovanni Codacci-Pisanelli, Jasmina Koeva-Balabanova, Angelo Virgilio Paradiso, Zorana Maravic, Vassiliki Fotaki, Núria Malats, Chiara Bernini, Simonetta Buglioni, Alastair Kent, Elisabetta Munzone, Ivica Belina, Jan Van Meerbeeck, Michael J Duffy, Beata Jagielska, Ettore Capoluongo
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine. Cancers 13 (3) (2021)
Paola Peinado, Alvaro Andrades, Marta Cuadros, María Isabel Rodríguez, Isabel F Coira, Daniel J Garcia, Juan Carlos Álvarez-Perez, Carlos Baliñas-Gavira, Alberto M Arenas, Juan Rodrigo Patiño-Mercau, Juan Sanjuan-Hidalgo, Octavio A Romero, Luis M Montuenga, Julian Carretero, Montserrat Sanchez-Cespedes, Pedro P Medina
Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models. Cancers 12 (12) (2020)
Irati Garmendia, María J Pajares, Francisco Hermida-Prado, Daniel Ajona, Cristina Bértolo, Cristina Sainz, Amaya Lavín, Ana B Remírez, Karmele Valencia, Haritz Moreno, Irene Ferrer, Carmen Behrens, Myriam Cuadrado, Luis Paz-Ares, Xosé R Bustelo, Ignacio Gil-Bazo, Daniel Alameda, Fernando Lecanda, Alfonso Calvo, Enriqueta Felip, Montse Sánchez-Céspedes, Ignacio I Wistuba, Rocio Granda-Diaz, Juan Pablo Rodrigo, Juana María García-Pedrero, Ruben Pio, Luis M Montuenga, Jackeline Agorreta
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib. American journal of respiratory and critical care medicine 200 (7) (2020)
Fernando Carazo, Cristina Bértolo, Carlos Castilla, Xabier Cendoya, Lucía Campuzano, Diego Serrano, Marian Gimeno, Francisco J Planes, Ruben Pio, Luis M Montuenga, Angel Rubio
DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC). Cancers 12 (7) (2020)
Mario Sanchez-Canteli, Rocio Granda-Díaz, Nagore Del Rio-Ibisate, Eva Allonca, Fernando López-Alvarez, Jackeline Agorreta, Irati Garmendia, Luis M Montuenga, Juana María García-Pedrero, Juan Pablo Rodrigo
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas. Cancer immunology, immunotherapy : CII 69 (10) (2020)
Francisco Hermida-Prado, Rocío Granda-Díaz, Nagore Del-Río-Ibisate, M Ángeles Villaronga, Eva Allonca, Irati Garmendia, Luis M Montuenga, Rene Rodriguez, Aitana Vallina, César Alvarez-Marcos, Juan Pablo Rodrigo, Juana María García-Pedrero
The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Cancers 11 (11) (2019)